Success for Sarah Jones

Sarah Jones team

L- R: Top row - Dr Akshay D’Cruz, Ms Lily Cheang, Ms Tammi Tang, Ms Darcey Kennedy, Dr Taylah Bennett. Bottom row - Ms Rochelle Sherlock, Dr Sarah Jones, Ms Iolanda Miceli

Dr Sarah Jones and her team in Monash University’s Rheumatology Research Laboratory have been awarded $500,000 from CUREator to support her new biotech GILZRx to run so-called ‘killer’ experiments to show that the development of a new anti-inflammatory therapeutic small molecule will reduce reliance on glucocorticoids for the treatment of autoimmune diseases and inflammatory disorders. Armed with this powerful data, GILZRx will be ready to receive investor funding for a multi-million-dollar drug discovery and development program. Professor Eric Morand provides clinical expertise to support the GILZRx commercialisation program.

About Monash University

Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.

With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.

As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.

For more news, visit Medicine, Nursing and Health Sciences or Monash University.